Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Ipek Özer Stillman"'
Publikováno v:
Clinical Ophthalmology. 13:225-232
Objectives Dry eye disease (DED) is a complex multifactorial condition of the ocular surface characterized by symptoms of ocular discomfort, irritation, and visual disturbance. Data previously reported from this study showed an increase in prevalence
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bc8b9778cda91a88a2b44401ae92e9b2
https://doi.org/10.2147/opth.s188314
https://doi.org/10.2147/opth.s188314
Publikováno v:
American Journal of Ophthalmology. 182:90-98
Purpose To provide current estimates of the prevalence of diagnosed dry eye disease (DED) and associated demographics among US adults aged ≥18 years. Design Cross-sectional, population-based survey. Methods Data were analyzed from 75 000 participan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a96b2024b6f6d7d6b166d1dfb7e92f0
https://doi.org/10.1016/j.ajo.2017.06.033
https://doi.org/10.1016/j.ajo.2017.06.033
Publikováno v:
American journal of ophthalmology. 198
To assess the proportion of comorbidities in patients with dry eye disease (DED) compared with matched patients without DED in a comprehensive US population.Retrospective case-control study.Healthcare records for insurance claims data, detailing medi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4babe6094668e0c37895a0957b158785
https://pubmed.ncbi.nlm.nih.gov/30312577
https://pubmed.ncbi.nlm.nih.gov/30312577
Autor:
Annie Guerin, Irina Pivneva, Ipek Özer Stillman, John L Bradley, Reza Dana, Debra A. Schaumberg, Amber M. Evans
Publikováno v:
American journal of ophthalmology. 202
Purpose To assess overall prevalence, annual prevalence, and incidence of dry eye disease (DED) in a large, representative population in the United States. Design Prevalence and incidence study. Methods Retrospective analysis using the Department of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aaa5af50f92b41e72629076a115148ac
https://pubmed.ncbi.nlm.nih.gov/30721689
https://pubmed.ncbi.nlm.nih.gov/30721689
Autor:
Ipek Özer Stillman, Bjorn Bolinder, J. Whalen, Dinara Makenbaeva, Apoorva Ambavane, Eugene Felber
Publikováno v:
Journal of Medical Economics. 19:445-461
A cost-effectiveness analysis was performed for sequential treatments of chronic myelogenous leukemia (CML) with tyrosine kinase inhibitors (TKIs) after failure of 1st line imatinib, from a commercial payer perspective in the US.A Markov model was de
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::44f4f9a949e7829953847b3fe95d307d
https://doi.org/10.3111/13696998.2015.1126285
https://doi.org/10.3111/13696998.2015.1126285
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Health technology assessment (HTA) has traditionally relied on cost-effectiveness analysis (CEA) as a cornerstone of evaluation of new therapies, assessing the clinical validity and utility, the efficacy, and the cost-effectiveness of new interventio
Externí odkaz:
https://doaj.org/article/3e43e21f0ebb4669ba58d98d49caea1f
Autor:
Mason W. Russell, W. Jacqueline Kwong, Ipek Özer-Stillman, Shane Kavanagh, Noah Haber, Jeffrey D. Miller
Publikováno v:
Clinical Therapeutics. 32:1768-1781
Background: Tapentadol immediate-release (IR) tablets are indicated for the treatment of moderate to severe acute pain. In clinical trials, tapentadol IR effectively reduced moderate to severe pain with improved tolerability compared with oxycodone I
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::44b286bc845747270b78b27e1777ca41
https://doi.org/10.1016/j.clinthera.2010.09.011
https://doi.org/10.1016/j.clinthera.2010.09.011
Publikováno v:
Journal of Medical Economics. 10:239-254
SummaryRimonabant, the first selective CB-1 receptor blocker, is expected to reduce cardiometabolic risk substantially. This study assesses the economics of such treatment in patients at elevated cardiometabolic risk.A Markov model was developed usin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a422b3b2604643224102a062edc20896
https://doi.org/10.3111/13696990701438629
https://doi.org/10.3111/13696990701438629
Autor:
Ipek Özer Stillman, Shailja Dixit, Irina Proskorovsky, Luis Hernández, Denis Getsios, Stephanie Chen, Catherine Saint-Laurent Thibault
Objective:This study evaluates the cost-effectiveness of memantine extended release (ER) as an add-on therapy to acetylcholinesterase inhibitor (AChEI) [combination therapy] for treatment of patients with moderate-to-severe Alzheimer’s disease (AD)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc7a5e22acaaa8cc9177b4961b9e64f9
Autor:
Ateesha F. Mohamed, Katherine E. Tranbarger-Freier, Jane Chang, Ipek Özer-Stillman, Lauren N. Strand
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 21(2)
Purpose: Gastrointestinal stromal tumor (GIST) is a relatively rare tumor that is treated with targeted therapies in advanced stages. Randomized clinical trials (RCTs) often require long follow-up and large sample sizes to evaluate overall survival (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a27626f7db0d81ccb5fe314c3a1401d2
https://pubmed.ncbi.nlm.nih.gov/25477532
https://pubmed.ncbi.nlm.nih.gov/25477532